Search

everythinglearnresearchcommunity

for

Search:↓

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Finasteride slightly improves prostate symptoms but has minimal difference from placebo.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Newly made nicotinamide compounds could potentially treat cancer.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Finasteride, often used for hair loss, can potentially cause cataracts.